SEBIA CAPI 3 HEMOGLOBIN(E)

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Available from:

Sebia Singapore Pte Ltd

Class:

Class B IVD

Manufactured by:

SEBIA

Therapeutic area:

Clinical chemistry

Therapeutic indications:

The CAPI 3 HEMOGLOBIN(E) kit is designed for the separation of the normal hemoglobins (A, A2 and F) in human blood samples, and for the detection of the major hemoglobin variants (S, C, E and D), by capillary electrophoresis in alkaline buffer (pH 9.4) with the SEBIA CAPILLARYS 3 instrument.The CAPILLARYS 3 instrument is an automated analyzer which performs a complete hemoglobin profile for the quantitative analysis of the normal hemoglobin fractions A, A2 and F and for the detection of major hemoglobin variants S, C, E and D. The assay is performed on the hemolysate of whole blood samples collected in tubes containing KEDTA as anticoagulant. For In Vitro Diagnostic Use.

Product summary:

Device System Info:-; Models: CAPILLARYS 3 OCTA - 1245, CAPILLARYS 3 TERA - 1246, CAPI 3 HEMOGLOBIN(E) - 2507, NORMAL Hb A2 CONTROL (5) - 4778, PATHOLOGICAL Hb A2 CONTROL - 4779, Hb AFSC CONTROL - 4792

Authorization date:

2020-12-09